Alopecia Universalis After Discontinuation of Pegylated Interferon and Ribavirin Combination Therapy for Hepatitis C: A Case Report

    March 2014 in “ Annals of Hepatology
    N. Gamal, Lucia Brodosi, Cosimo Misciali, Annalisa Patrizi, G. Vukatana, Nazzarena Malavolta, Mauro Bernardi, Pietro Andreone
    Image
    Studysummary This case report describes irreversible alopecia universalis following discontinuation of Peg-IFN/RBV treatment for chronic hepatitis C, highlighting potential autoimmune side effects of interferon-based therapies.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    10 / 10 results